Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Lotiglipron [usan]
2. Yi10w1k93a
3. Schembl22009794
4. Bdbm450633
5. Us10676465, Example 10
6. Pf-07081532
7. 1h-benzimidazole-6-carboxylic Acid, 2-[[4-[(2s)-2-(5-chloro-2-pyridinyl)-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2s)-2-oxetanylmethyl]-
8. 2-({4-[(s)-2-(5-chloropyridin-2-yl)-2-methylbenzo[1,3]dioxol-4-yl]piperidin-1-yl}methyl)-1-{[(s)-oxetan-2-yl]methyl}-1h-benzimidazole-6-carboxylic Acid
9. 2401892-75-7
| Molecular Weight | 575.1 g/mol |
|---|---|
| Molecular Formula | C31H31ClN4O5 |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 98.9 |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 938 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
47
PharmaCompass offers a list of Lotiglipron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lotiglipron manufacturer or Lotiglipron supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lotiglipron manufacturer or Lotiglipron supplier.
PharmaCompass also assists you with knowing the Lotiglipron API Price utilized in the formulation of products. Lotiglipron API Price is not always fixed or binding as the Lotiglipron Price is obtained through a variety of data sources. The Lotiglipron Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lotiglipron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lotiglipron, including repackagers and relabelers. The FDA regulates Lotiglipron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lotiglipron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lotiglipron supplier is an individual or a company that provides Lotiglipron active pharmaceutical ingredient (API) or Lotiglipron finished formulations upon request. The Lotiglipron suppliers may include Lotiglipron API manufacturers, exporters, distributors and traders.
Lotiglipron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lotiglipron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lotiglipron GMP manufacturer or Lotiglipron GMP API supplier for your needs.
A Lotiglipron CoA (Certificate of Analysis) is a formal document that attests to Lotiglipron's compliance with Lotiglipron specifications and serves as a tool for batch-level quality control.
Lotiglipron CoA mostly includes findings from lab analyses of a specific batch. For each Lotiglipron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lotiglipron may be tested according to a variety of international standards, such as European Pharmacopoeia (Lotiglipron EP), Lotiglipron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lotiglipron USP).
